Literature DB >> 23729602

Should neonatal hyperparathyroidism associated with mucolipidosis II/III be treated pharmacologically?

Taciane Alegra, Gabriela Cury, Luiz Alberto Todeschini, Ida V D Schwartz.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23729602     DOI： 10.1515/jpem-2012-0356

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN： 0334-018X            Impact factor:   1.634


× No keyword cloud information.
  3 in total

1.  Clinical Characterization of Mucolipidoses II and III: A Multicenter Study.

Authors:  Taciane Alegra; Fernanda Sperb-Ludwig; Nicole Ruas Guarany; Erlane M Ribeiro; Charles M Lourenço; Chong Ae Kim; Eugênia R Valadares; Marcial Francis Galera; Angelina X Acosta; Dafne Dain Gandelman Horovitz; Ida Vanessa Doederlein Schwartz
Journal:  J Pediatr Genet       Date:  2019-09-24

2.  Early characteristic radiographic changes in mucolipidosis II.

Authors:  Lillian M Lai; Ralph S Lachman
Journal:  Pediatr Radiol       Date:  2016-08-15

3.  Secondary Hyperparathyroidism in Children with Mucolipidosis Type II (I-Cell Disease): Irish Experience.

Authors:  Ritma Boruah; Ahmad Ardeshir Monavari; Tracey Conlon; Nuala Murphy; Andreea Stroiescu; Stephanie Ryan; Joanne Hughes; Ina Knerr; Ciara McDonnell; Ellen Crushell
Journal:  J Clin Med       Date:  2022-03-02       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.